Steven Lo — Chief Commercial Officer at Puma Biotechnology

Mr. Steven Lo has been Chief Commercial Officer of Puma Biotechnology, Inc. since September 8, 2015. Mr. Lo is responsible for leading the Puma Biotechnology commercial operations. Mr. Lo served as the Senior Vice President of Oncology at Corcept Therapeutics Inc. from February 2015 to September 4, 2015. Mr. Lo served as the Chief Commercial Officer and Senior Vice President at Corcept Therapeutics Inc. from November 2013 to February 2015. Mr. Lo served as Vice President of Commercial Operations at Corcept Therapeutics Inc. since September 2010 until November 2013. Mr. Lo has 15 years of commercial experience in the pharmaceutical and biotechnology industry. Mr. Lo served with Genentech, Inc. from December 1997 to September 2010. At Genentech, Mr. Lo held a number of positions, including Senior Director of Oncology Marketing, where he prepared and led the first U.S. launch of Herceptin in adjuvant HER2 positive breast cancer and also worked with Genentech's then ex-U.S. marketing partner, Roche, to develop the global adjuvant launch strategy for Herceptin in adjuvant HER2 positive breast cancer. Mr. Lo received a B.S. in Microbiology from the University of California, Davis and a Master of Health Administration from the University of Southern California.